RP Bio Inc. (KOSDAQ:314140)

RP Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,886	14,133	3,208	16,816	6,269	7,368
Short-Term Investments	8,168	4,702	9,350	1,488	1,449	1,919
Cash & Short-Term Investments	15,054	18,836	12,558	18,304	7,718	9,286
Cash Growth	-9.03%	49.99%	-31.39%	137.16%	-16.89%	-10.96%
Accounts Receivable	16,695	17,659	19,995	20,773	21,320	16,929
Other Receivables	-	38.22	353.66	332.09	112.17	70.66
Receivables	16,695	17,997	20,349	21,705	21,433	17,000
Inventory	27,127	23,962	34,109	38,590	22,569	16,389
Prepaid Expenses	-	212.71	162.67	177.36	74.56	93.5
Other Current Assets	1,474	104.95	535.72	2,266	477.83	423.35
Total Current Assets	60,350	61,112	67,714	81,043	52,272	43,192
Property, Plant & Equipment	94,883	95,921	96,975	88,727	88,970	84,991
Long-Term Investments	66.09	66.09	66.09	66.09	66.09	66.09
Other Intangible Assets	560.79	495.5	335.15	453.91	538.48	729.33
Long-Term Deferred Tax Assets	1,203	741.13	1.49	-	318.05	586.86
Other Long-Term Assets	734.51	1,133	1,096	2,798	1,573	881.91
Total Assets	157,797	159,499	166,218	173,158	143,737	130,447
Accounts Payable	19,835	17,330	20,737	29,781	24,529	15,412
Accrued Expenses	-	1,334	1,741	2,010	1,779	1,451
Short-Term Debt	16,000	25,000	25,000	34,873	36,826	39,350
Current Portion of Leases	933.09	601.39	1,007	676.85	651.95	343.22
Current Income Taxes Payable	575.44	252.07	25.14	710.76	218.3	113
Other Current Liabilities	7,630	6,658	8,986	10,579	7,385	8,542
Total Current Liabilities	44,973	51,175	57,496	78,630	71,389	65,211
Long-Term Leases	3,938	4,593	4,774	2,635	2,858	384.1
Long-Term Deferred Tax Liabilities	-	-	-	237.08	-	-
Other Long-Term Liabilities	552.9	515.29	584.61	519.18	501.27	630.13
Total Liabilities	52,766	57,196	63,471	82,021	74,748	66,323
Common Stock	4,333	4,333	4,333	4,097	3,294	3,294
Additional Paid-In Capital	65,349	65,349	65,346	58,826	37,431	37,431
Retained Earnings	35,412	32,684	33,128	28,268	24,160	20,283
Treasury Stock	-81.47	-81.47	-81.47	-81.47	-81.47	-81.47
Comprehensive Income & Other	17.88	17.88	21.56	27.33	123.52	108.95
Total Common Equity	105,031	102,303	102,747	91,137	64,927	61,035
Shareholders' Equity	105,031	102,303	102,747	91,137	68,989	64,124
Total Liabilities & Equity	157,797	159,499	166,218	173,158	143,737	130,447
Total Debt	20,871	30,194	30,781	38,185	40,336	40,078
Net Cash (Debt)	-5,817	-11,359	-18,223	-19,881	-32,618	-30,791
Net Cash Per Share	-673.27	-1313.16	-1950.62	-2791.65	-4962.17	-4629.89
Filing Date Shares Outstanding	8.65	8.65	8.65	8.18	6.57	6.57
Total Common Shares Outstanding	8.65	8.65	8.65	8.18	6.57	6.57
Working Capital	15,377	9,937	10,218	2,413	-19,117	-22,020
Book Value Per Share	12142.57	11827.16	11878.43	11145.28	9877.25	9283.22
Tangible Book Value	104,471	101,808	102,411	90,683	64,388	60,306
Tangible Book Value Per Share	12077.74	11769.88	11839.68	11089.77	9795.34	9172.30
Land	15,781	15,441	15,441	15,441	15,441	15,441
Buildings	64,460	62,866	57,487	56,367	55,187	55,187
Machinery	56,820	55,985	54,558	46,904	44,016	38,501
Construction In Progress	220.3	798	2,264	832.74	523.48	1,136

Source: S&P Global Market Intelligence. Standard template. Financial Sources.